Skip to main content

Journals in Life sciences general

Cell Investigation

  • ISSN: 3050-5380
Cell Investigation strives to publish original research findings that are of great significance or broad conceptual or technical advances in all areas of life sciences such as molecular and cell biology etc. The journal has an international authorship and a broad scope including basic experimental and translational research and clinical trial. The journal aims to providing a premier platform for disseminating cutting-edge research in the rapidly evolving field of normal and tumoral biology.We seek studies that present advanced conceptions, methodologies, or technics that push the boundaries of scientific understanding in any areas of life sciences, including (but not limited to) the following topics:Cell Homeostasis and StressCell MetabolismCell Senescence and Aging Cell DeathCell SignallingCell Modulation and Manipulation Cell-Based Drug Development, Screening, and ToxicologyCell-Based Therapies and Translational StudiesCancer Biology & MicrobiomeStem Cell and Cellular DifferentiationNeuroscienceImmunityMolecular & Cell BiologyMolecular Genetics & Epigenetics Omics & Systems Biology BionanotechnologyArtificial Intelligence in Health CareThe journal welcomes original research articles, letters, reviews, short communications, comments, and methodological papers that contribute to the advancement of knowledge in these areas. By providing a focused and inclusive platform, the journal aims to catalyze progress in life sciences.Editorial Board

Cell Reports

  • ISSN: 2211-1247
  • 5 Year impact factor: 8.5
  • Impact factor: 7.5
The Cell Reports Portfolio includes gold open-access journals that span life, medical, and physical science. Our mission is to make cutting-edge research and methodologies across disciplines available to a wide readership.Cell Reports publishes high-quality papers across the entire life sciences spectrum. The primary criterion for publication in Cell Reports is new biological insight.Cell Reports features cutting-edge research, with a focus on a shorter, single-point story, called a report, in addition to a longer research article format and resources. Resources highlight significant technical advances or major informational data sets that provide new biological insight. Reviews covering recent literature in emerging and active fields are also welcome.The professional in-house editors of Cell Reports work closely with authors, reviewers, and the journal's scientific advisory board. The advisory board comprises current and future leaders in their respective fields who guide the journal with regard to its scope, its content, and the quality of the papers it publishes. However, editorial decisions at Cell Reports are made independently by its in-house editors.Visit the Cell Press website for more information about Cell Reports - http://www.cell.com/cell-reports/home

Clinics in Geriatric Medicine

  • ISSN: 0749-0690
  • 5 Year impact factor: 4.6
  • Impact factor: 3.1
Clinics in Geriatric Medicine provides the latest diagnostic and therapeutic information in the field of geriatrics. Published four times a year—in February, May, August, and November—each issue covers a single topic in geriatrics, including cardiovascular disease, common geriatric disorders (such as sarcopenia and frailty), dermatology, emergency care, oncology, patient care, psychiatry, and much more.

Comparative Biochemistry and Physiology - Part A: Molecular & Integrative Physiology

  • ISSN: 1095-6433
  • 5 Year impact factor: 2.2
  • Impact factor: 2.1
Comparative Biochemistry & Physiology (CBP) publishes papers in comparative, environmental and evolutionary physiology.Part A: Molecular and Integrative Physiology (CBPA), focuses on physiological systems, including behavior, circulation, development, excretion, ion regulation, endocrinology, locomotory, nervous, nutrition, respiration, and thermal biology. Most studies address regulatory mechanisms and span multiple levels of biological organization.All four CBP journals support and follow the editorial direction from all the major societies in the field:Australia & New Zealand Society of Comparative Physiology and Biochemistry (ANZSCPB)American Physiological Society (APS)Canadian Society of Zoologists (CSZ)Deutsche Zoologische Gesellschaft (DZG)European Society of Comparative Physiology and Biochemistry (ESCPB)Japanese Society for Comparative Physiology and Biochemistry (JSCPB)South American Society for Comparative Physiology and Biochemistry (SASCPB)Societe de Physiologie (SDP)Society for Experimental Biology (SEB)Society for Integrative & Comparative Biology (SICB)Benefits to authorsCBP journals are focused on promoting the authors and the work published in the journal:All articles are carefully evaluated directly by the Editors-in-Chief who are leading experts in their field.Availability: contact the Editor-in-Chief for any questions you may have.The Journal will provide upon request free PDFs to all authors who may not have access to their articles via their institution or library.Publication is free to authors (no color or page charges).Supporting open access: if your funding body or institution requires your article to be open access, CBP offers that option. Please see details here.Reuse figures from any CBP article via "get rights and content" hyperlink available within each article (below author names and affiliations) on ScienceDirect.Please click here for more information on more general author services.Other CBP journals Part B (CBPB): Biochemistry & Molecular Biology Part C (CBPC): Toxicology & Pharmacology Part D (CBPD): Genomics & Proteomics

Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology

  • ISSN: 1096-4959
  • 5 Year impact factor: 2
  • Impact factor: 1.9
Comparative Biochemistry & Physiology (CBP) publishes papers in comparative, environmental and evolutionary physiology.Part B: Biochemical and Molecular Biology (CBPB), focuses on biochemical physiology, primarily bioenergetics/energy metabolism, cell biology, cellular stress responses, enzymology, intermediary metabolism, macromolecular structure and function, gene regulation, evolutionary genetics. Most studies focus on biochemical or molecular analyses that have clear ramifications for physiological processes.All four CBP journals support and follow the editorial direction from all the major societies in the field:Australia & New Zealand Society of Comparative Physiology and Biochemistry (ANZSCPB)American Physiological Society (APS)Canadian Society of Zoologists (CSZ)Deutsche Zoologische Gesellschaft (DZG)European Society of Comparative Physiology and Biochemistry (ESCPB)Japanese Society for Comparative Physiology and Biochemistry (JSCPB)South American Society for Comparative Physiology and Biochemistry (SASCPB)Societe de Physiologie (SDP)Society for Experimental Biology (SEB)Society for Integrative & Comparative Biology (SICB)Benefits to authorsCBP journals are focused on promoting the authors and the work published in the journal:All articles are carefully evaluated directly by the Editors-in-Chief who are leading experts in their field.Availability: contact the Editor-in-Chief for any questions you may have.The Journal will provide upon request free PDFs to all authors who may not have access to their articles via their institution or library.Publication is free to authors (no color or page charges).Supporting open access: if your funding body or institution requires your article to be open access, CBP offers that option. Please see details here.Reuse figures from any CBP article via "get rights and content" hyperlink available within each article (below author names and affiliations) on ScienceDirect.Please click here for more information on more general author services.Other CBP journals Part A (CBPA): Molecular & Integrative Physiology Part C (CBPC): Toxicology & Pharmacology Part D (CBPD): Genomics and Proteomics

Comparative Biochemistry and Physiology - Part D: Genomics and Proteomics

  • ISSN: 1744-117X
  • 5 Year impact factor: 2.5
  • Impact factor: 2.2
Comparative Biochemistry & Physiology (CBP) publishes papers in comparative, environmental and evolutionary physiology.Part D: Genomics and Proteomics (CBPD), focuses on “omics” approaches to physiology, including comparative and functional genomics, metagenomics, transcriptomics, proteomics, metabolomics, and lipidomics. Most studies employ “omics” and/or system biology to test specific hypotheses about molecular and biochemical mechanisms underlying physiological responses to the environment. We encourage papers that address fundamental questions in comparative physiology and biochemistry rather than studies with a focus that is purely technical, methodological or descriptive in nature.All four CBP journals support and follow the editorial direction from all the major societies in the field:Australia & New Zealand Society of Comparative Physiology and Biochemistry (ANZSCPB)American Physiological Society (APS)Canadian Society of Zoologists (CSZ)Deutsche Zoologische Gesellschaft (DZG)European Society of Comparative Physiology and Biochemistry (ESCPB)Japanese Society for Comparative Physiology and Biochemistry (JSCPB)South American Society for Comparative Physiology and Biochemistry (SASCPB)Societe de Physiologie (SDP)Society for Experimental Biology (SEB)Society for Integrative & Comparative Biology (SICB)Benefits to authorsCBP journals are focused on promoting the authors and the work published in the journal:All articles are carefully evaluated directly by the Editors-in-Chief who are leading experts in their field.Availability: contact the Editor-in-Chief for any questions you may have.The Journal will provide upon request free PDFs to all authors who may not have access to their articles via their institution or library.Publication is free to authors (no color or page charges).Supporting open access: if your funding body or institution requires your article to be open access, CBP offers that option. Please see details here.Reuse figures from any CBP article via "get rights and content" hyperlink available within each article (below author names and affiliations) on ScienceDirect.Please click here for more information on more general author services.Other CBP journals Part A (CBPA): Molecular & Integrative Physiology Part B (CBPB): Biochemistry & Molecular Biology Part C (CBPC): Toxicology & Pharmacology

Computational and Structural Biotechnology Journal

  • ISSN: 2001-0370
  • 5 Year impact factor: 5
  • Impact factor: 4.4
Computational and Structural Biotechnology Journal (CSBJ) is an online gold open access journal publishing research articles and reviews after full peer review. All articles are published, without barriers to access, immediately upon acceptance. CSBJ is composed of the following Sections:CSBJ: General SectionCSBJ: The Smart Hospital SectionCSBJ: Nanoscience & Advanced Materials SectionCSBJ: Quantum Biology & Biophotonics SectionCSBJ: General Section focuses on functional and mechanistic understanding of how molecular components in a biological process work together through the application of computational methods. Structural data may provide such insights, but they are not a pre-requisite for publication in this section. For more details and specific areas of interest within this section, please visit: https://www.csbj.org/CSBJ: The Smart Hospital Section focuses on new digital and automated technologies transforming health and care systems. Clinical and piloting data may provide practical insights on implementing digital and automated technologies in real-world smart hospital setting, but they are not a pre-requisite for publication in this section. For more details and specific areas of interest within this section, please visit: https://csbj-smarthospital.org/CSBJ: Nanoscience and Advanced Materials Section focuses on advancing the scientific knowledge and technological innovation at the crossroads of nanoscience, materials science, chemistry, physics, and biomedical engineering. The section welcomes submissions covering a wide spectrum of topics within the overarching domains of nanoscience and advanced materials, enhancing our understanding of the nanoscale world and its transformative applications. For more details and specific areas of interest within this section, please visit: http://csbj-nano.org/CSBJ: Quantum Biology and Biophotonics Section places a strong transdisciplinary emphasis on understanding biological systems that potentially harness quantum-mechanical processes. This section also focuses on the development and application of optics and photonic tools, methods, and technologies to address questions in quantum biology and its implications for biomedical and health sciences. Studies based on experimental approaches, computational simulations, and theoretical developments that are focused on this emphasis are welcome but are not a prerequisite for publication in this section. For more details and specific areas of interest within this section, please visit: http://csbj-qbio.org/The journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence and enables the rapid publication of papers under the following categories:o Research Articles o Review Articles o Mini Reviews o Innovation Reports o Short Communications o Method Articles o Database Articles o Software/Web Server Articles o EditorialsCSBJ is published by Elsevier on behalf of Research Networks.

Current Advances in Cancer Research

  • ISSN: 0895-9803
Current Advances in Cancer Research is a monthly current literature searching service which is fast, comprehensive, economical and easy to use. It enables pure and applied scientists to keep abreast of the ever-increasing literature being published in their subject area, by providing a subject categorized listing of titles, authors, bibliographic details and authors' addresses. Titles are presented under appropriate subject headings with full cross references. Contents: Major subject areas covered include: Epidemiology of cancer; Aetiology of cancer; Cancer genetics and cytogenetics; Molecular and cellular tumor biology; Tumor immunology; Oncogenic viruses; Tumor endocrinology; Diagnosis and prognosis; Chemotherapy; Radiotherapy; Immunotherapy; Haematologic reconstitution; Surgery; Comparative assessments of therapies; Treatment monitoring and evaluation; Clinical investigations by organ site; Childhood cancer; Side effects and complications of cancer and its treatment; Psychology of cancer.

Current Biology

  • ISSN: 0960-9822
  • 5 Year impact factor: 9.8
  • Impact factor: 8.1
Current Biology is a general journal that publishes original research across all areas of biology together with an extensive and varied set of editorial sections. A primary aim of the journal is to foster communication across fields of biology, both by publishing important findings of general interest from diverse fields and through highly accessible editorial articles that explicitly aim to inform non-specialists.Current Biology publishes papers reporting findings in any area of biology that have sufficient claim to be of general interest?this could be, for example, because the advance is important for a specific field, or because it is intrinsically of wide interest to biologists generally. We have several formats for publishing original research (articles, reports, and correspondences); see our article types page for details.Visit the Cell Press website for more information about Current Biology - http://www.cell.com/current-biology/homeVisit the Cell Press website for more information about Current Biology - http://www.cell.com/current-biology/home

Current Research in Biotechnology

  • ISSN: 2590-2628
  • 5 Year impact factor: 4
  • Impact factor: 3.6
Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines.Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals . All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Current Research in Biotechnology topics covered include "core" biotechnology disciplines such as genetic and molecular engineering; plant and animal biotechnology; food biotechnology; energy biotechnology; environmental biotechnology; and tissue, cell and pathway engineering. Submissions of manuscripts focused on biotech-associated topics in a broad sense (topics on the interface between technology and biological systems) are also encouraged, including on methods and technology with relevance for biology; molecular medicine, gene therapy, and cellular therapies; drug delivery; bioinformatics, biological big data, in silico modelling, and other computational approaches with a relevance for biology; systems biology and "omics" technologies; wearable technology and other digital health applications; natural products; analytical biotechnology and analytical techniques with applications in biology, bioproduction technologies; approaches and practices with relevance for biotech industry and business; nanobiotechnology and nanomaterials for biological applications; chemical biotechnology; pharmaceutical biotechnology; biomaterials and materials for biological applications; as well as biosensors and bioimaging technology.Current Research in Biotechnology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating impactful and reproducible basic and translational research findings.Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous.Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to https://www.elsevier.com/conflictsofinterest